Recent Finacing
Recent Raise
Biolex Therapeutics develops platform technologies to optimize monoclonal antibody properties, produce hard-to-express proteins, and advance experimental therapeutics such as Locteron, a time-release interferon alfa for hepatitis C.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors